AQR Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $436K | Buy |
26,029
+2,074
| +9% | +$34.8K | ﹤0.01% | 2690 |
|
2025
Q1 | $368K | Buy |
23,955
+4,732
| +25% | +$72.7K | ﹤0.01% | 2594 |
|
2024
Q4 | $424K | Buy |
19,223
+1,646
| +9% | +$36.3K | ﹤0.01% | 2325 |
|
2024
Q3 | $317K | Buy |
17,577
+1,433
| +9% | +$25.8K | ﹤0.01% | 2368 |
|
2024
Q2 | $262K | Buy |
+16,144
| New | +$262K | ﹤0.01% | 2323 |
|
2015
Q1 | – | Sell |
-206,919
| Closed | -$11.9M | – | 2308 |
|
2014
Q4 | $11.9M | Hold |
206,919
| – | – | 0.02% | 610 |
|
2014
Q3 | $11.1M | Buy |
206,919
+103,108
| +99% | +$5.54M | 0.03% | 562 |
|
2014
Q2 | $5.44M | Buy |
+103,811
| New | +$5.44M | 0.01% | 866 |
|